Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
1376
BeOne Medicines Ltd
ONC
$42.5B
| $19.8M | 0.01% |
110,971
+33,253
| +43% | +$7.66M |
|
1377
PUT
Hershey
HSY
$37.6B
| $19.8M | 0.01% |
79,200
+12,800
| +19% | +$3.36M |
|
1378
Relay Therapeutics
RLAY
$4.47B
| $19.8M | 0.01% |
+1,574,157
| New | +$19.6M |
|
1379
Ball Corp
BALL
$16.9B
| $19.8M | 0.01% |
339,536
-112,342
| -25% | -$6.09M |
|
1380
PUT
Intuit
INTU
$98.6B
| $19.7M | 0.01% |
43,100
+10,700
| +33% | +$4.69M |
|
1381
Sweetgreen
SG
$846M
| $19.7M | 0.01% |
1,538,814
+1,376,747
| +849% | +$12.7M |
|
1382
Hancock Whitney
HWC
$5.96B
| $19.7M | 0.01% |
513,892
-158,609
| -24% | -$5.89M |
|
|
SAGE
1383
DELISTED
Sage Therapeutics
SAGE
| $19.7M | 0.01% |
418,110
+51,447
| +14% | +$2.56M |
|
|
CVAC
1384
DELISTED
CureVac
CVAC
| $19.6M | 0.01% |
1,883,659
+93,351
| +5% | +$835K |
|
|
CVSA
1385
Covista Inc
CVSA
$4.52B
| $19.6M | 0.01% |
570,591
+285,601
| +100% | +$11.4M |
|
1386
Alexandria Real Estate Equities
ARE
$9.12B
| $19.6M | 0.01% |
172,404
-272,274
| -61% | -$32.4M |
|
1387
Moderna
MRNA
$61.5B
| $19.6M | 0.01% |
160,963
+41,872
| +35% | +$5.59M |
|
1388
ACV Auctions
ACVA
$1.27B
| $19.5M | 0.01% |
1,131,318
+446,815
| +65% | +$6.83M |
|
1389
Norfolk Southern
NSC
$79.3B
| $19.5M | 0.01% |
86,109
-745,364
| -90% | -$158M |
|
|
MRO
1390
PUT
DELISTED
Marathon Oil Corporation
MRO
| $19.5M | 0.01% |
847,800
+55,800
| +7% | +$1.31M |
|
1391
Casella Waste Systems
CWST
$5.97B
| $19.5M | 0.01% |
215,273
+186,485
| +648% | +$16.6M |
|
1392
Broadstone Net Lease
BNL
$4.38B
| $19.5M | 0.01% |
1,260,737
-957,920
| -43% | -$15.3M |
|
1393
PUT
Air Products & Chemicals
APD
$68B
| $19.3M | 0.01% |
64,600
-14,000
| -18% | -$3.99M |
|
1394
Sarepta Therapeutics
SRPT
$1.98B
| $19.3M | 0.01% |
168,907
-414,017
| -71% | -$53.4M |
|
1395
Pan American Silver
PAAS
$22B
| $19.3M | 0.01% |
1,321,366
-692,284
| -34% | -$11.4M |
|
1396
Corcept Therapeutics
CORT
$13.3B
| $19.3M | 0.01% |
865,459
-1,569,693
| -64% | -$36.1M |
|
1397
CALL
Simon Property Group
SPG
$71.2B
| $19.2M | 0.01% |
166,600
+23,300
| +16% | +$2.54M |
|
1398
Atlassian
TEAM
$42.8B
| $19.2M | 0.01% |
114,493
-138,507
| -55% | -$22.2M |
|
1399
Wabash National
WNC
$493M
| $19.2M | 0.01% |
748,760
+492,353
| +192% | +$12.1M |
|
1400
Employers Holdings
EIG
$877M
| $19.2M | 0.01% |
512,826
+98,391
| +24% | +$3.85M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.